Daniel Parks

444 total citations
22 papers, 340 citations indexed

About

Daniel Parks is a scholar working on Pulmonary and Respiratory Medicine, Epidemiology and Infectious Diseases. According to data from OpenAlex, Daniel Parks has authored 22 papers receiving a total of 340 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Pulmonary and Respiratory Medicine, 4 papers in Epidemiology and 3 papers in Infectious Diseases. Recurrent topics in Daniel Parks's work include Liver Disease Diagnosis and Treatment (3 papers), HIV/AIDS drug development and treatment (3 papers) and HIV Research and Treatment (2 papers). Daniel Parks is often cited by papers focused on Liver Disease Diagnosis and Treatment (3 papers), HIV/AIDS drug development and treatment (3 papers) and HIV Research and Treatment (2 papers). Daniel Parks collaborates with scholars based in United States, United Kingdom and India. Daniel Parks's co-authors include S. Leeson, Shannon Ferrante, Yogesh Punekar, Rafael Alfonso‐Cristancho, Michelle D. Hackshaw, Saurabh Nagar, P. W. Lane, Sarah Cockle, Kwan Lee and Eric Bradford and has published in prestigious journals such as Hepatology, Annals of the Rheumatic Diseases and AIDS.

In The Last Decade

Daniel Parks

22 papers receiving 318 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Daniel Parks United States 12 87 71 54 48 41 22 340
Liping Guo China 15 63 0.7× 31 0.4× 135 2.5× 39 0.8× 5 0.1× 36 500
R. S. Eydelloth United States 12 60 0.7× 17 0.2× 119 2.2× 29 0.6× 11 0.3× 18 566
Christine Falcoz United Kingdom 13 26 0.3× 253 3.6× 77 1.4× 241 5.0× 16 0.4× 19 490
Nadia Soudani Lebanon 13 28 0.3× 58 0.8× 174 3.2× 30 0.6× 7 0.2× 24 464
Simone V. Generoso Brazil 11 25 0.3× 126 1.8× 35 0.6× 133 2.8× 4 0.1× 14 490
S. Mercier France 10 13 0.1× 18 0.3× 73 1.4× 78 1.6× 51 1.2× 13 367
Pooja S. Salvi United States 4 21 0.2× 24 0.3× 42 0.8× 87 1.8× 3 0.1× 11 346
John Brejda United States 9 10 0.1× 21 0.3× 58 1.1× 35 0.7× 19 0.5× 26 390
Natali Vega‐Magaña Mexico 12 15 0.2× 11 0.2× 170 3.1× 33 0.7× 12 0.3× 35 406
S Bunyaratvej Thailand 13 21 0.2× 42 0.6× 15 0.3× 18 0.4× 4 0.1× 30 436

Countries citing papers authored by Daniel Parks

Since Specialization
Citations

This map shows the geographic impact of Daniel Parks's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Daniel Parks with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Daniel Parks more than expected).

Fields of papers citing papers by Daniel Parks

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Daniel Parks. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Daniel Parks. The network helps show where Daniel Parks may publish in the future.

Co-authorship network of co-authors of Daniel Parks

This figure shows the co-authorship network connecting the top 25 collaborators of Daniel Parks. A scholar is included among the top collaborators of Daniel Parks based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Daniel Parks. Daniel Parks is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Kumar, Rahul, et al.. (2021). 898. Effectiveness and Tolerability of DTG + 3TC in Clinical Practice: Evidence in PLHIV from Real-world Data. Open Forum Infectious Diseases. 8(Supplement_1). S540–S540. 2 indexed citations
2.
3.
4.
Parks, Daniel, et al.. (2019). Comparative efficacy and safety and dolutegravir and lamivudine in treatment naive HIV patients. AIDS. 33(11). 1739–1749. 19 indexed citations
5.
Ramachandran, Sulabha, Daniel Parks, Milena Kurtinecz, David A. Roth, & Rafael Alfonso‐Cristancho. (2018). An indirect comparison of intravenous and subcutaneous belimumab efficacy in patients with SLE and high disease activity. Journal of Comparative Effectiveness Research. 7(6). 581–593. 4 indexed citations
6.
7.
8.
Parks, Daniel, et al.. (2016). An indirect comparison of HbA1c treatment effect with albiglutide and exenatide 2.0 mg QW using the Bucher method. Diabetes Metabolic Syndrome and Obesity. 9. 163–163. 4 indexed citations
9.
Cockle, Sarah, Necdet B. Gunsoy, Daniel Parks, et al.. (2016). Comparative effectiveness of mepolizumab and omalizumab in severe asthma: An indirect treatment comparison. Respiratory Medicine. 123. 140–148. 41 indexed citations
10.
Black, Libby, et al.. (2014). Incremental Hospital Costs Associated With Comorbidities Of Prematurity. Value in Health. 17(3). A158–A158. 8 indexed citations
11.
Hackshaw, Michelle D., et al.. (2014). Persistence and Compliance with Pazopanib in Patients with Advanced Renal Cell Carcinoma Within a U.S. Administrative Claims Database. Journal of Managed Care Pharmacy. 20(6). 603–610. 24 indexed citations
12.
Parks, Daniel, et al.. (2014). Assessing Statistical Methods for Causal Inference in Observational Data. Value in Health. 17(7). A731–A731. 1 indexed citations
13.
Parks, Daniel, Xiwu Lin, Jeffery L. Painter, et al.. (2013). A proposed modification to Hy's law and Edish criteria in oncology clinical trials using aggregated historical data. Pharmacoepidemiology and Drug Safety. 22(6). 571–578. 14 indexed citations
14.
Lin, Xiwu, Daniel Parks, Jeffery L. Painter, et al.. (2012). Validation of Multivariate Outlier Detection Analyses Used to Identify Potential Drug-Induced Liver Injury in Clinical Trial Populations. Drug Safety. 35(10). 865–875. 11 indexed citations
15.
Lane, P. W., et al.. (2012). An Integrated Analysis of Liver Safety Data from Orlistat Clinical Trials. Obesity Facts. 5(4). 485–494. 21 indexed citations
16.
Lin, Xiwu, Daniel Parks, Lei Zhu, et al.. (2012). Truncated Robust Distance for Clinical Laboratory Safety Data Monitoring and Assessment. Journal of Biopharmaceutical Statistics. 22(6). 1174–1192. 4 indexed citations
17.
Hammoud, Ghassan M., Kenneth J. Vega, Mark F. Sands, et al.. (2003). 347 Poor tolerability to high dose PEG interferon and ribavirin in HIV/HCV coinfected patients; initial results from a randomized multicenter trial. Hepatology. 38. 327–327. 3 indexed citations
18.
Parks, Daniel, et al.. (1992). Calcium and Phosphorus Metabolism and Eggshell Formation of Hens Fed Different Amounts of Calcium. Poultry Science. 71(3). 482–489. 69 indexed citations
19.
Parks, Daniel, et al.. (1992). Calcium and Phosphorus Metabolism and Eggshell Thickness in Laying Hens Producing Thick or Thin Shells. Poultry Science. 71(3). 490–498. 27 indexed citations
20.
Roytblat, Leonid, et al.. (1990). Dopamine and hepatic oxygen supply – demand relationship. Canadian Journal of Physiology and Pharmacology. 68(8). 1165–1169. 14 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Liping Guo Breakdown of academic impact, for papers by R. S. Eydelloth Breakdown of academic impact, for papers by Christine Falcoz Breakdown of academic impact, for papers by Nadia Soudani Breakdown of academic impact, for papers by Simone V. Generoso Breakdown of academic impact, for papers by S. Mercier Breakdown of academic impact, for papers by Pooja S. Salvi Breakdown of academic impact, for papers by John Brejda Breakdown of academic impact, for papers by Natali Vega‐Magaña Breakdown of academic impact, for papers by S Bunyaratvej
Rankless by CCL
2026